Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cancer Research|December 3, 1999
Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodiesG Huls, I A Heijnen, E Cuomo, et al.
Leukemia|November 27, 2012
MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogenyS J Horton, J Jaques, C Woolthuis, et al.
Bone Marrow Transplantation|April 13, 2010
Auto-SCT induces a phenotypic shift from CMP to GMP progenitors, reduces clonogenic potential and enhances in vitro and in vivo cycling activity defined by (18)F-FLT PET scanningC Woolthuis, A Agool, S Olthof, et al.
The Netherlands Journal of Medicine|February 12, 2020
Association of vitamin B12, methylmalonic acid, and functional parametersB H R Wolffenbuttel, H J C M Wouters, W H A de Jong, et al.
Journal of Bacteriology|November 14, 1997
Effects of different carbon fluxes on G1 phase duration, cyclin expression, and reserve carbohydrate metabolism in Saccharomyces cerevisiaeH H Silljé, E G ter Schure, A J Rommens, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysisF M Montes de Jesus, T C Kwee, M Nijland, et al.
American Journal of Hematology|November 28, 2023
R-miniCHOP versus R-CHOP in elderly patients with diffuse large B-cell lymphoma: A propensity matched population-based studyD Al-Sarayfi, M Brink, M E D Chamuleau, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2012
The circulating platelet count is not dictated by the liver, but may be determined in part by the bone marrow: analyses from human liver and stem cell transplantationsT Lisman, G Pittau, F J T Leite, et al.
Leukemia|July 16, 2011
Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AMLH J M de Jonge, C M Woolthuis, A Z Vos, et al.
Leukemia Research|May 1, 2013
Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blastsL H van der Helm, N J G M Veeger, M van Marwijk Kooy, et al.
Pageof 4